Phase III JEWEL study of lurasidone meets primary endpoint in patients with schizophrenia Jan. 11, 2019
Sirion Biotech collaborates with Denali Therapeutics to develop gene therapies for CNS diseases Jan. 10, 2019
Interaction of CSF with graphene causes changes in its vibrational energies that distinguish ALS Jan. 10, 2019
Tarlige tablets receive approval in Japan for the treatment of peripheral neuropathic pain Jan. 9, 2019
RSS